Exoskeleton Market Size & Growth Forecast 2027–2036, By Segments (Mobility, Technology, Extremity, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Exoskeleton Market size was valued at USD 694.46 million in 2026 and is anticipated to grow at a 13.78% CAGR from 2027 to 2036, attaining USD 2.53 billion by 2036. The industry revenue for 2027 is calculated at USD 775.02 million.

• Base Year Value (2026): USD 694.46 million
• CAGR (2027-2036): 13.78%
• Forecast Year Value (2036): USD 2.53 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Exoskeleton Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 47.84% share in 2026, supported by early adoption across healthcare, industrial, and defense sectors, along with strong rehabilitation infrastructure and enterprise procurement capacity.
  • Asia Pacific is expected to expand at an 18.48% CAGR, driven by industrial automation, investment in advanced medical devices, and growing adoption of rehabilitation technologies and ergonomic workplace solutions.

• Segment Momentum:

  • Mobile exoskeletons captured 60.52% of the market in 2026 because their portability supports rehabilitation, industrial, and assistive applications, allowing deployment across diverse real-world environments with greater operational flexibility.
  • Non-powered exoskeletons are growing rapidly as organizations seek lightweight, cost-effective ergonomic support that reduces fatigue without requiring batteries, charging, or complex system maintenance.

• Market Expansion Drivers:

  • Aging population and rising stroke and spinal cord injury cases driving rehabilitation exoskeleton demand.
  • Increasing industrial musculoskeletal disorders driving workplace exoskeleton adoption for injury prevention.
  • Expanding insurance reimbursement and AI-enabled wearable robotics improving accessibility and clinical deployment.

• Leading Market Participants:

  Major players in the exoskeleton market include Ekso Bionics Holdings, Inc. (United States), CYBERDYNE Inc. (Japan), ReWalk Robotics Ltd. (Israel), Lockheed Martin Corporation (United States), Hocoma AG (Switzerland), SuitX (United States), Rex Bionics Ltd. (New Zealand), Panasonic Holdings Corporation (Japan), DIH Medical (China), Ottobock SE & Co. KGaA (Germany).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 694.46 million
  • 2027 Estimated Market Size: USD 775.02 million.
  • Projected Market Size: USD 2.53 billion by 2036
  • Growth Forecasts: 13.78% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Mobile (Mobility) | Powered (Technology) | Lower Body (Extremity) | Healthcare (End Use)
  • Emerging Opportunity Segment: Mobile (Mobility) | Non-powered (Technology) | Upper Body (Extremity) | Industry (End Use)

Market Growth Drivers and Industry Trends

Aging population and rising stroke and spinal cord injury cases driving rehabilitation exoskeleton demand

The exoskeleton market is benefiting from the growing need for rehabilitation support as aging populations and increasing cases of stroke and spinal cord injuries create greater demand for assistive technologies. Rehabilitation exoskeletons can support structured movement training and help patients perform repetitive mobility exercises under clinical supervision.

Increasing industrial musculoskeletal disorders driving workplace exoskeleton adoption for injury prevention

Workplace-related musculoskeletal disorders are encouraging greater adoption of wearable support technologies, strengthening the exoskeleton market across industrial environments. Exoskeletons can assist workers during physically demanding activities by reducing strain during repetitive or load-intensive tasks, supporting injury prevention and improving ergonomic conditions.

Expanding insurance reimbursement and AI-enabled wearable robotics improving accessibility and clinical deployment

Expanding insurance reimbursement can improve access to advanced rehabilitation technologies, while AI-enabled wearable robotics are enhancing the functionality of the exoskeleton market. Intelligent systems can adapt assistance to user movement and rehabilitation requirements, supporting broader clinical deployment and making wearable robotic technologies more practical for patient care.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Aging population and rising stroke and spinal cord injury cases driving rehabilitation exoskeleton demand	2.00%	High	North America, Europe	High	Near Term
Increasing industrial musculoskeletal disorders driving workplace exoskeleton adoption for injury prevention	1.80%	Moderate	Asia Pacific, North America	Medium	Mid Term
Expanding insurance reimbursement and AI-enabled wearable robotics improving accessibility and clinical deployment	1.60%	High	Europe, North America	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America accounted for a 47.84% share of the exoskeleton market in 2026, supported by advanced healthcare infrastructure, strong rehabilitation capabilities, and growing interest in technologies that enhance mobility and physical assistance. Demand is being encouraged by applications in rehabilitation, workplace safety, logistics, and industrial operations, where exoskeletons can assist movement, reduce physical strain, and support worker productivity. The region's established robotics and wearable technology ecosystem also facilitates product development and integration with healthcare and industrial workflows. Increasing attention to occupational ergonomics and rehabilitation outcomes, together with continued innovation in lightweight and sensor-enabled systems, is strengthening regional adoption.

Asia Pacific represents the fastest-growing regional market, driven by expanding industrial automation, manufacturing activity, and healthcare modernization. Increasing workplace safety requirements and efforts to reduce musculoskeletal strain are creating opportunities for wearable robotic technologies across industrial environments. At the same time, improvements in rehabilitation infrastructure and greater awareness of assistive technologies are supporting healthcare applications. Growing investment in robotics, electronics, and advanced manufacturing capabilities is also encouraging development of more accessible exoskeleton systems, while the region's expanding workforce and industrial base provide a broad application landscape.

Key Country Insights

United States

Clinical Adoption Momentum

The U.S. exoskeleton market advances through rehabilitation, workplace safety, and defense applications. Developers prioritize clinical validation, ergonomic improvements, and software integration to expand practical deployment across healthcare providers and industrial users.

Japan

Aging Care Applications

Japan applies exoskeleton technologies to rehabilitation services and elderly care as healthcare providers seek mobility assistance solutions. Product development focuses on compact designs, user comfort, and dependable long-term operation for clinical and caregiving environments.

South Korea

Robotics Integration Strategy

South Korea combines robotics expertise with exoskeleton innovation for industrial and medical applications. Developers invest in intelligent control systems, lightweight materials, and wearable technologies that enhance usability across multiple commercial settings.

Germany

Industrial Workforce Support

Germany emphasizes exoskeleton adoption within manufacturing and logistics to improve worker ergonomics and reduce physical strain. Companies collaborate with industrial employers to refine wearable systems that integrate efficiently into existing operational environments.

France

Rehabilitation Technology Focus

France supports exoskeleton deployment through rehabilitation centers and medical technology initiatives. Companies emphasize patient mobility outcomes, clinician usability, and collaborative research that strengthens practical healthcare adoption of wearable robotic systems.

Italy

Assistive Mobility Development

Italy expands exoskeleton applications through rehabilitation facilities and industrial workplace initiatives. Manufacturers focus on adaptable wearable systems, user-centered design, and partnerships with healthcare organizations to improve mobility assistance and occupational support.

Segment Leadership and Growth Trends

 

Mobility Segment Analysis: Mobile (Largest & Fastest-Growing Segment)

The mobile segment led the exoskeleton market and was also the fastest-growing mobility segment, accounting for a 60.52% share in 2026. Mobile exoskeletons provide users with greater freedom of movement while delivering physical assistance during rehabilitation, industrial tasks, and mobility-support applications. Their ability to augment strength, endurance, and movement without restricting users to fixed locations makes them attractive across a broad range of use cases. Increasing interest in assistive technologies, workforce ergonomics, and rehabilitation solutions is strengthening demand for mobile exoskeleton systems.

Technology Segment Analysis: Powered (Largest Segment) vs Non-powered (Fastest-Growing Segment)

Powered exoskeletons held the largest share of the exoskeleton market in 2026. Their leading position reflects the ability to actively assist users through motors, actuators, and electronic control systems, providing support for movement, lifting, walking, or rehabilitation activities. Technological improvements in sensing, control, battery systems, and wearable design are enhancing the functionality of powered systems and expanding their applicability. Demand from healthcare and occupational settings, where controlled assistance can reduce physical strain or support mobility, continues to reinforce the segment's established position.

Non-powered exoskeletons are experiencing faster growth as organizations and users seek lightweight, mechanically assisted solutions that can provide physical support without reliance on powered actuation. These systems can reduce muscular strain during repetitive or physically demanding activities while offering relatively simple operation. Their suitability for industrial ergonomics, workplace assistance, and mobility support is encouraging wider adoption. Growing attention to worker safety and fatigue reduction is further increasing interest in practical exoskeleton designs that can be deployed across varied operating environments.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Mobility	Mobile, Fixed/Stationary	Mobile	Mobile
Technology	Powered, Non-powered	Powered	Non-powered
Extremity	Upper Body, Lower Body, Full Body	Lower Body	Upper Body
End Use	Healthcare, Military, Industry	Healthcare	Industry

Competitive Landscape and Market Positioning

Prominent players in the exoskeleton market:

1. Ekso Bionics Holdings Inc. (United States)

2. CYBERDYNE Inc. (Japan)

3. ReWalk Robotics Ltd. (Israel)

4. Lockheed Martin Corporation (United States)

5. Hocoma AG (Switzerland)

6. SuitX (United States)

7. Rex Bionics Ltd. (New Zealand)

8. Panasonic Holdings Corporation (Japan)

9. DIH Medical (China)

10. Ottobock SE & Co. KGaA (Germany)

The exoskeleton market is advancing through rapid integration of robotics and assistive mobility technologies. Enhanced mechanical design is improving user adaptability and movement support. The exoskeleton market is also driven by ongoing innovation aimed at increasing rehabilitation effectiveness and industrial usability.

Industry Development/News

Company Name	Date	Key Development
Ascentiz	Jan-26	Ascentiz unveiled the modular H+K exoskeleton system at CES 2026, featuring upgraded knee modules and high-power hip modules. The system integrates BodyOS and AI-driven motion recognition to provide adaptive support across diverse terrains, enhancing user endurance and stability while reducing joint impact, marking a significant advancement in consumer-focused wearable robotics for outdoor and athletic applications.
OYMotion Technology	Jan-26	OYMotion Technology partnered with Melexis to integrate advanced sensor technology into its rehabilitation and assistive robotics portfolio. The collaboration focuses on enhancing robot perception and control for dexterous hands and lower-limb exoskeletons, leveraging OYMotion's expertise in EMG/EEG AI and lightweight mechanical design to accelerate the commercialization of high-precision devices for clinical and industrial sectors.
Wandercraft	May-25	Wandercraft initiated clinical trials for its Personal Exoskeleton, a self-balancing wearable device engineered for individuals with severe mobility impairments. By utilizing AI-powered mechanisms to restore natural gait and posture, the company aims to move beyond clinical rehabilitation environments into personal, hands-free mobility, potentially providing wheelchair users with increased autonomy and significant improvements in functional independence.
German Bionic	Jan-25	German Bionic launched the Apogee ULTRA, its most powerful industrial exoskeleton capable of providing up to 36 kg of lifting support. Designed for logistics, manufacturing, and healthcare environments, the device employs machine learning to adapt to user physiology and tasks, addressing critical labor shortages and worker safety requirements through high-capacity augmentation and data-driven performance monitoring.
RoboCT	Dec-24	RoboCT’s UGO Series rehabilitation exoskeleton received CE certification as a medical device. This regulatory milestone, supported by passing international safety and performance standards, facilitates the company's strategic expansion into the European Union market, allowing it to provide standardized, robot-assisted physical therapy solutions for patients with lower-limb motor dysfunction and neurological conditions.
Hippos Exoskeleton	Nov-25	Hippos Exoskeleton unveiled an AI-driven, textile-based knee sleeve designed to prevent ACL injuries through integrated micro-airbag technology. The system uses on-device AI to analyze biomechanical data in real-time and deploy stabilization within 50 milliseconds during high-risk maneuvers. This development represents a shift toward soft, wearable robotics aimed at real-time injury prevention in professional athletics and military operations.
Wandercraft	Mar-24	Wandercraft secured $75 million in Series D funding, supported by a strategic partnership with Renault, to accelerate the development of its exoskeleton portfolio, including the Atalante X and Eve models. This capital injection enhances the company's capabilities in scaling production and deploying advanced rehabilitation robotics for clinical settings, while also supporting its broader R&D programs in humanoid robotics.
Nike	Mar-24	Nike entered the wearable robotics space with the unveiling of Project Amplify, a powered footwear system for lower-limb augmentation. The system provides robotic assistance to optimize movement efficiency and endurance during running and walking, signaling a strategic convergence between high-performance athletic footwear design and medical-grade exoskeleton technology.
Ekso Bionics	Dec-22	Ekso Bionics acquired the Human Motion and Control business unit from Parker Hannifin, including the established Indego lower-limb exoskeleton product line. This acquisition significantly strengthened Ekso Bionics’ market position in medical rehabilitation, expanding its portfolio of powered orthotic devices and accelerating its R&D capabilities in robot-assisted physical therapy and patient-centered mobility solutions.
CYBERDYNE Inc.	Jun-22	CYBERDYNE Inc. formed a strategic alliance with LIFESCAPES and entered a collaborative agreement with Malaysia’s Social Security Organization (SOCSO) to expand its Cybernics Treatment programs. By integrating its hybrid assistive limb (HAL) technology into clinical rehabilitation services, the company has broadened its international operational footprint and solidified its role in evidence-based robotic treatment for patients with severe paralysis.